Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma - Concepedia

Concepedia

Publication | Closed Access

Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma

47

Citations

27

References

2020

Year

Bodoor Yaseen, Henry Lopez, Zeinab Taki, Sara Zafar, Henrique Rosario, Bahja Ahmed Abdi, Shivanee Vigneswaran, Fiona Xing, Nikita Arumalla, Simon Black,

Abstract

IL-31/IL-31RA is confirmed as a candidate pro-fibrotic pathway, which may contribute to skin and lung fibrosis in a subset of scleroderma patients.

References

	Year	Citations
Near-optimal probabilistic RNA-seq quantification Nicolas Bray, Harold Pimentel, Páll Melsted, Nature Biotechnology Functional GenomicsEngineeringGeneticsRna Structure PredictionComputational Biology	2016	10.4K
2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen, Arthritis & Rheumatism	2013	3.3K
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease Oliver Distler, Kristin B. Highland, Martina Gahlemann, New England Journal of Medicine	2019	1.5K
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial Donald P. Tashkin, Michael D. Roth, Philip J. Clements, The Lancet Respiratory Medicine Sls IiMycophenolate MofetilInflammatory Lung DiseaseAdvanced Lung DiseaseSystemic Scleroderma	2016	1K
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice Stacey R. Dillon, Cindy A. Sprecher, Angela Hammond, Nature Immunology InflammationCytokineActivated T CellsInterleukin 31Autoimmune Disease	2004	982
Standardized Quantification of Pulmonary Fibrosis in Histological Samples Ralf‐Harto Hübner, Wolfram Gitter, Nour Eddine El Mokhtari, BioTechniques	2008	795
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, New England Journal of Medicine	2018	567
Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. Arnold E. Postlethwaite, M A Holness, Hitoshi Katai, Journal of Clinical Investigation ImmunologyPathologyExtracellular Matrix ProteinsInflammationIii Collagen	1992	492
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis Svetlana I. Nihtyanova, Benjamin Schreiber, Voon H Ong, Arthritis & Rheumatology	2014	455
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma Janet Pope, Nicholas Bellamy, James R. Seibold, Arthritis & Rheumatism	2001	423

Page 1